|
541 |
Steroid Drugs as an Adjunct for Reducing the Incidence of Proliferative Vitreoretinopathy after Rhegmatogenous Retinal Detachment Surgery: A Meta-Analysis of Randomized Controlled Studies Enthalten in Ophthalmic research Bd. 66, 2023, Nr. 1: 599-610. 12 S.
|
|
|
542 |
Effect of Atropine 0.01% Eye Drops on the Difference in Refraction and Axial Length between Right and Left Eyes Enthalten in Ophthalmic research Bd. 66, 2023, Nr. 1: 496-505. 10 S.
|
|
|
543 |
Tislelizumab plus Chemotherapie beim Ösophagus-Plattenepithelkarzinom Enthalten in Zeitschrift für Gastroenterologie Bd. 61, 2023, Nr. 11: 1440-1442
|
|
|
544 |
Effect of a Toothpaste Containing Surface Pre-Reacted Glass-Ionomer Filler on the Remineralization of Artificial Carious Enamel Lesions in situ Enthalten in Caries research Bd. 56, 2023, Nr. 5-6: 447-454. 8 S.
|
|
|
545 |
Cardiorenal Outcomes with Finerenone in Asian Patients with Chronic Kidney Disease and Type 2 Diabetes: A FIDELIO-DKD post hoc Analysis Enthalten in American journal of nephrology Bd. 54, 2023, Nr. 9-10: 370-378. 9 S.
|
|
|
546 |
Effect of Lacticaseibacillus rhamnosus L8020 on the abundance of periodontal pathogens in individuals with intellectual disability: a randomized clinical trial Enthalten in Quintessence international Bd. 54, 2023, Nr. 5: 372-383
|
|
|
547 |
Erstlinientherapie beim metastasierten hormonsensitiven Prostatakarzinom Enthalten in Aktuelle Urologie Bd. 54, 2023, Nr. 03: 186-188
|
|
|
548 |
Effectiveness of oral premedication of meloxicam, ketorolac, dexamethasone, and ibuprofen on the success rate of inferior alveolar nerve block in patients with symptomatic irreversible pulpitis: a prospective, double-blind, randomized controlled trial Enthalten in Quintessence international Bd. 54, 2023, Nr. 2: 92-99
|
|
|
549 |
Clinical Outcomes of Patients with C3G or IC-MPGN Treated with the Factor D Inhibitor Danicopan: Final Results from Two Phase 2 Studies Enthalten in American journal of nephrology Bd. 53, 2023, Nr. 10: 687-700. 14 S.
|
|
|
550 |
Comparative Efficacy and Acceptability of 12 Phosphorus-Lowering Drugs in Adults with Hyperphosphatemia and Chronic Kidney Disease: A Systematic Review and Network Meta-Analysis Enthalten in Blood purification Bd. 52, 2023, Nr. 7-8: 609-620. 12 S.
|
|